Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05274022 · ClinicalTrials.gov registry record · NA

Rehabilitation Strategies to Improve Outcomes For Patients With a Lower Extremity Fracture

A NA study of Tibial Fractures and Femoral Fracture, sponsored by Brian W. Noehren.

Completed
Registry status
NA
Development phase
66
Enrollment target
2
Study locations

NCT05274022 is a NA study of Tibial Fractures and Femoral Fracture that has completed, run by Brian W. Noehren. The registered enrollment target is 66 participants, below the 335-participant average among 12 other Tibial Fractures trials with a reported enrollment target (80% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05274022, a NA study of Tibial Fractures and Femoral Fracture, has completed, sponsored by Brian W. Noehren.

COMPLETED
Registry status
NA
Development phase
66 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to evaluate speed high intensity interval training (HIIT) walking program following an orthopedic trauma.

Interventions

  • OTHER Standard of Care Physical Therapy Program
  • OTHER Speed Walking Intervention

Study Locations (2)

Kentucky

  • University of Kentucky - Lexington

Tennessee

  • Vanderbilt University - Nashville

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2022-03-03
Est. Completion 2025-12-18
Phase NA

Sponsor

Brian W. Noehren

3 total trials

What the Registry Record Tells You About NCT05274022

The ClinicalTrials.gov registry entry for NCT05274022 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 335-participant average among 12 other Tibial Fractures trials with a reported enrollment target (80% lower). The listed sponsor is Brian W. Noehren, which has 3 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Tibial Fractures appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care Physical Therapy Program is the first listed.

NCT05274022 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Kentucky, Tennessee.

Frequently Asked Questions

What is clinical trial NCT05274022 about?

NCT05274022 is a clinical study titled "Rehabilitation Strategies to Improve Outcomes For Patients With a Lower Extremity Fracture". The purpose of this study is to evaluate speed high intensity interval training (HIIT) walking program following an orthopedic trauma.

What is the current status of trial NCT05274022?

This trial is currently completed. It is a NA study. The enrollment target is 66 participants. The study started on 2022-03-03. Estimated completion is 2025-12-18.

What conditions does trial NCT05274022 study?

This clinical trial studies the following conditions: Tibial Fractures, Femoral Fracture.

What interventions are being tested in trial NCT05274022?

The interventions under investigation include: Standard of Care Physical Therapy Program (OTHER), Speed Walking Intervention (OTHER).

Who is sponsoring clinical trial NCT05274022?

This trial is sponsored by Brian W. Noehren, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05274022 being conducted?

This trial has 2 study locations across Kentucky, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Tibial Fractures

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.